![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Goldshield Grp | LSE:GSD | London | Ordinary Share | GB0002893823 | ORD 5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 486.25 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
RNS Number:1262O Goldshield Group PLC 30 July 2003 For Immediate Release: 30 July 2003 Goldshield Group plc Filing of Defence to Warfarin Litigation Goldshield Group plc announces that it has today filed and served its defence to the claim brought by the Secretary of State for Health and certain other claimants arising from the sale and supply of the anticoagulant drug Warfarin between 1996 and 2000. The Secretary of State's claim alleged that Goldshield and certain other parties had been involved in anti-competitive behaviour resulting in the National Health Service paying an excess aggregate reimbursement cost for Warfarin during this period. Goldshield intends to defend the claim vigorously. ENDS For further information please contact: Nicola How / Tim Anderson 020 7466 5000 Buchanan Communications This information is provided by RNS The company news service from the London Stock Exchange END MSCFBLFXXDBBBBD
1 Year Goldshield Chart |
1 Month Goldshield Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions